Central Cass’ Zaine Blixt dribbles towards the basket against Kindred’s Brooks Bakko during the ND Division A Boys Basketball ...

Gaia posted double-digit year-over-year revenue growth, driven in part by an increase in the streaming video provider’s ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

The program is made up of a full-time team of individuals who will provide 7-day-a-week services focused on improving public ...